265 related articles for article (PubMed ID: 32155980)
1. Purinergic Receptors: Elucidating the Role of these Immune Mediators in HIV-1 Fusion.
Freeman TL; Swartz TH
Viruses; 2020 Mar; 12(3):. PubMed ID: 32155980
[TBL] [Abstract][Full Text] [Related]
2. P2X-selective purinergic antagonists are strong inhibitors of HIV-1 fusion during both cell-to-cell and cell-free infection.
Swartz TH; Esposito AM; Durham ND; Hartmann BM; Chen BK
J Virol; 2014 Oct; 88(19):11504-15. PubMed ID: 25031337
[TBL] [Abstract][Full Text] [Related]
3. P2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor Interactions.
Giroud C; Marin M; Hammonds J; Spearman P; Melikyan GB
J Virol; 2015 Sep; 89(18):9368-82. PubMed ID: 26136569
[TBL] [Abstract][Full Text] [Related]
4. Toll-Like Receptor 2 Ligation Enhances HIV-1 Replication in Activated CCR6+ CD4+ T Cells by Increasing Virus Entry and Establishing a More Permissive Environment to Infection.
Bolduc JF; Ouellet M; Hany L; Tremblay MJ
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928019
[TBL] [Abstract][Full Text] [Related]
5. Strain-Dependent Activation and Inhibition of Human Immunodeficiency Virus Entry by a Specific PF-68742 Stereoisomer.
Zhao C; Princiotto AM; Nguyen HT; Zou S; Zhao ML; Zhang S; Herschhorn A; Farrell M; Pahil K; Melillo B; Sambasivarao SV; Abrams C; Smith AB; Madani N; Sodroski J
J Virol; 2019 Nov; 93(21):. PubMed ID: 31391272
[TBL] [Abstract][Full Text] [Related]
6. P2X1 Selective Antagonists Block HIV-1 Infection through Inhibition of Envelope Conformation-Dependent Fusion.
Soare AY; Malik HS; Durham ND; Freeman TL; Alvarez R; Patel F; Satija N; Upadhyay C; Hioe CE; Chen BK; Swartz TH
J Virol; 2020 Feb; 94(6):. PubMed ID: 31852781
[TBL] [Abstract][Full Text] [Related]
7. Putative roles of purinergic signaling in human immunodeficiency virus-1 infection.
Pacheco PA; Faria RX; Ferreira LG; Paixão IC
Biol Direct; 2014 Oct; 9():21. PubMed ID: 25351961
[TBL] [Abstract][Full Text] [Related]
8. The Role of Integrin α
Kasarpalkar N; Deb B; Kumar P; Bhor VM
OMICS; 2020 Jul; 24(7):437-450. PubMed ID: 32522079
[TBL] [Abstract][Full Text] [Related]
9. IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread.
Compton AA; Bruel T; Porrot F; Mallet A; Sachse M; Euvrard M; Liang C; Casartelli N; Schwartz O
Cell Host Microbe; 2014 Dec; 16(6):736-47. PubMed ID: 25464829
[TBL] [Abstract][Full Text] [Related]
10. Syncytial apoptosis signaling network induced by the HIV-1 envelope glycoprotein complex: an overview.
Nardacci R; Perfettini JL; Grieco L; Thieffry D; Kroemer G; Piacentini M
Cell Death Dis; 2015 Aug; 6(8):e1846. PubMed ID: 26247731
[TBL] [Abstract][Full Text] [Related]
11. IP-10 Promotes Latent HIV Infection in Resting Memory CD4
Wang Z; Yin X; Ma M; Ge H; Lang B; Sun H; He S; Fu Y; Sun Y; Yu X; Zhang Z; Cui H; Han X; Xu J; Ding H; Chu Z; Shang H; Wu Y; Jiang Y
Front Immunol; 2021; 12():656663. PubMed ID: 34447368
[TBL] [Abstract][Full Text] [Related]
12. Relationships Between HIV-Mediated Chemokine Coreceptor Signaling, Cofilin Hyperactivation, Viral Tropism Switch and HIV-Mediated CD4 Depletion.
He S; Wu Y
Curr HIV Res; 2019; 17(6):388-396. PubMed ID: 31702526
[TBL] [Abstract][Full Text] [Related]
13. The role of cytokines in the pathogenesis and treatment of HIV infection.
Catalfamo M; Le Saout C; Lane HC
Cytokine Growth Factor Rev; 2012; 23(4-5):207-14. PubMed ID: 22738931
[TBL] [Abstract][Full Text] [Related]
14. Fusion Stage of HIV-1 Entry Depends on Virus-Induced Cell Surface Exposure of Phosphatidylserine.
Zaitseva E; Zaitsev E; Melikov K; Arakelyan A; Marin M; Villasmil R; Margolis LB; Melikyan GB; Chernomordik LV
Cell Host Microbe; 2017 Jul; 22(1):99-110.e7. PubMed ID: 28704658
[TBL] [Abstract][Full Text] [Related]
15. Palmitic Acid Is a Novel CD4 Fusion Inhibitor That Blocks HIV Entry and Infection.
Lee DY; Lin X; Paskaleva EE; Liu Y; Puttamadappa SS; Thornber C; Drake JR; Habulin M; Shekhtman A; Canki M
AIDS Res Hum Retroviruses; 2009 Dec; 25(12):1231-41. PubMed ID: 20001317
[TBL] [Abstract][Full Text] [Related]
16. HIV persistence: chemokines and their signalling pathways.
Evans VA; Khoury G; Saleh S; Cameron PU; Lewin SR
Cytokine Growth Factor Rev; 2012; 23(4-5):151-7. PubMed ID: 22749173
[TBL] [Abstract][Full Text] [Related]
17. Role of Abl kinase and the Wave2 signaling complex in HIV-1 entry at a post-hemifusion step.
Harmon B; Campbell N; Ratner L
PLoS Pathog; 2010 Jun; 6(6):e1000956. PubMed ID: 20585556
[TBL] [Abstract][Full Text] [Related]
18. Evolution of Host Target Cell Specificity During HIV-1 Infection.
Council OD; Joseph SB
Curr HIV Res; 2018; 16(1):13-20. PubMed ID: 29268687
[TBL] [Abstract][Full Text] [Related]
19. Global phosphoproteomics of CCR5-tropic HIV-1 signaling reveals reprogramming of cellular protein production pathways and identifies p70-S6K1 and MK2 as HIV-responsive kinases required for optimal infection of CD4+ T cells.
Wiredja DD; Tabler CO; Schlatzer DM; Li M; Chance MR; Tilton JC
Retrovirology; 2018 Jul; 15(1):44. PubMed ID: 29970186
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 envelope glycoprotein stimulates viral transcription and increases the infectivity of the progeny virus through the manipulation of cellular machinery.
Ran X; Ao Z; Trajtman A; Xu W; Kobinger G; Keynan Y; Yao X
Sci Rep; 2017 Aug; 7(1):9487. PubMed ID: 28842659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
